Jakarta – The National Food and Drug Control Agency, or BPOM, has given the green light to conduct clinical trials on the use of anti-parasitic drug Ivermectin to treat Covid-19 patients.
In an official statement released in March, the World Health Organization (WHO) advised Ivermectin to be only used for Covid-19 treatments within clinical trials.